IP Library Granted Patent US 12,471,822
Granted Patent B2
US 12,471,822 · App. 17/987,232 · Granted Nov 18, 2025

Systems and devices for detecting coronary artery disease using magnetic field maps

Inventors: Vineet Erasala (Mason, OH); Jon Von Stein (Columbus Grove, OH); Tatiana Sedlak (Strongsville, OH); Julia Prince (Toronto, CA); Anthony Senagore (Holland, MI); Rhea Malhotra (Mason, OH); Emmanuel T. Setegn (Mason, OH); Benjamin Donaldson Moore (Mason, OH); Peeyush Shrivastava (Mason, OH)
Assignee: SB Technology, Inc.
A61B5/243A61B5/329A61B5/33A61B5/352A61B5/355A61B5/6887A61B5/742G01R33/0076G01R33/26A61B2562/0223A61B2562/046A61B2562/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,471,822
App. No.
17/987,232
Granted
Nov 18, 2025
Kind
B2
Abstract

In an aspect, the present disclosure provides a method comprising: (a) identifying a first negative and positive electromagnetic dipoles in a first electromagnetic field map associated with a heart of the individual at a first time; (b) identifying a second negative and positive electromagnetic dipoles in a second electromagnetic field map associated with the heart of the individual at a second time; (c) determining a first angle based on the first negative and positive electromagnetic dipoles; (d) determining a second angle based on the second negative and positive electromagnetic dipoles; and (e) determining a presence, an absence, or a likelihood of coronary artery disease in the individual, based at least in part on (i) whether the first angle differs from the second angle by at least 100 degrees, or (ii) whether there is a presence of a third electromagnetic dipole in the first or the second electromagnetic field map.

Claims (35)

1 . A system for determining a presence, an absence, or a likelihood of coronary artery disease in an individual, comprising:

(1) a sensing device configured to sense a magnetic field associated with an individual, wherein the device comprises:

a. a movable base unit;

b. an arm having a proximal end and a distal end, the proximal end being coupled to the moveable base unit by a first joint, the first joint configured so that the arm moves relative to the movable base unit with at least one degree of freedom; and

c. an array of one or more optically pumped magnetometers coupled to the distal end of the arm, the array of one or more optically pumped magnetometers configured to sense the magnetic field associated with the individual; and

(2) a non-transitory computer readable medium encoded with a computer program comprising instructions executable by a processor configured to cause the processor to:

i. receive, from the sensing device, a first magnetic field associated with a heart of the individual at a first time when a R-wave is recorded, wherein the first time when the R-wave is recorded corresponds to a depolarization phase of the heart of the individual;

ii. generate a first electromagnetic field map based on the first magnetic field associated with the heart of the individual at the first time, wherein the first electromagnetic field map is a R-wave electromagnetic field map;

iii. identify a first negative electromagnetic dipole and a first positive electromagnetic dipole in the first electromagnetic field map;

iv. receive, from the sensing device, a second magnetic field associated with the heart of the individual at a second time when a T-wave is recorded, wherein the second time when the T-wave is recorded corresponds to a repolarization phase of the heart of the individual;

v. generate a second electromagnetic field map based on the second magnetic field associated with the heart of the individual at the second time, wherein the second electromagnetic field map is a T-wave electromagnetic field map;

vi. identify a second negative electromagnetic dipole and a second positive electromagnetic dipole in the second electromagnetic field map;

vii. determine a first angle based on the first negative electromagnetic dipole and the first positive electromagnetic dipole, and a second angle based on the second negative electromagnetic dipole and the second positive electromagnetic dipole; and

viii. determine the presence or the absence the coronary artery disease in the individual, based at least in part on (i) whether the first angle differs from the second angle by 100 degrees to 170 degrees, or (ii) whether there is a presence of a third electromagnetic dipole in either the first electromagnetic field map or the second electromagnetic field map.

2 . The system of claim 1 , wherein the sensing device comprises a shield configured to shield the device from one or more environmental magnetic fields, wherein the shield is configured to at least partially enclose a portion of a body of the individual which is associated with the magnetic field.

3 . The system of claim 2 , wherein the portion of the body of the individual which is associated with the magnetic field is at least a portion of a chest of the individual.

4 . The system of claim 2 , wherein the shield comprises two or more layers.

5 . The system of claim 2 , wherein the shield comprises permalloy or mumetal.

6 . The system of claim 1 , wherein the arm comprises a proximal segment and a distal segment, and wherein a second joint is positioned between the proximal segment and the distal segment and is configured so that the distal segment articulates relative to the proximal segment.

7 . The system of claim 1 , wherein the array of one or more optically pumped magnetometers is movably coupled to the distal end of the arm so that the array of the one or more optically pumped magnetometers moves relative to the arm with at least one degree of freedom.

8 . The system of claim 1 , wherein the array of one or more optically pumped magnetometers is arranged to match a generalized contour of a portion of a body of the individual.

9 . The system of claim 1 , wherein the computer program comprises instructions configured to cause the processor to further filter a sensed magnetic field.

10 . The system of claim 7 , further comprising a gradiometer, and wherein the computer program comprises instructions configured to cause the processor to filter the sensed magnetic field by cancelling out a magnetic field sensed by the gradiometer.

11 . The system of claim 9 , wherein the computer program comprises instructions configured to cause the processor to filter the sensed magnetic field by subtracting a frequency-based measurement from the magnetic field.

12 . The system of claim 1 , wherein the computer program comprises instructions configured to cause the processor to further generate a visual representation of the magnetic field comprising a waveform.

13 . The system of claim 1 , wherein the coronary artery disease comprises cardiac myocyte ischemia or cardiac myocyte ischemia with associated epicardial coronary artery disease.

14 . The system of claim 1 , wherein the computer program comprises instructions configured to cause the processor to further determine the presence, the absence, or the likelihood of the coronary artery disease in the individual, based at least in part on (iii) a parameter selected from the group consisting of: dipole parameters, integrated MCD parameters, integrated ECD parameters, mean PCD parameters, isointegral parameters, field map correlation parameters, R_peak pegged dipole parameters, pseudo current arrow parameters, extrema circle parameters, phase space embedding parameters using delta coordinates, and phase space embedding parameters using time delay coordinates, or (iv) a visualization selected from the group consisting of: a STAG plot, a T_peak MFM plot, a field map animation, pseudo current density arrows, an MCD plot, and an ECD plot.

15 . The system of claim 14 , wherein the computer program comprises instructions configured to cause the processor to further determine the presence, the absence, or the likelihood of the coronary artery disease in the individual, based at least in part on the parameter or the visualization.

16 . The system of claim 1 , wherein the presence of the coronary artery disease in the individual is determined based on a presence of at least one abnormality from among (i) whether the first angle differs from the second angle by at least 100 degrees, (ii) whether there is a presence of a third electromagnetic dipole in either the first electromagnetic field map or the second electromagnetic field map, (iii) the parameter, and (iv) the visualization.

17 . A non-transitory computer-readable medium comprising machine executable code that, upon execution by one or more computer processors, implements a method for determining a presence, an absence, or a likelihood of coronary artery disease in an individual, the method comprising:

(a) identifying a first negative electromagnetic dipole and a first positive electromagnetic dipole in a first electromagnetic field map associated with a heart of the individual at a first time;

(b) identifying a second negative electromagnetic dipole and second positive electromagnetic dipole in a second electromagnetic field map associated with the heart of the individual at a second time;

(c) determining a first angle based on the first negative electromagnetic dipole and the first positive electromagnetic dipole;

(d) determining a second angle based on the second negative electromagnetic dipole and the second positive electromagnetic dipole;

determining the presence, the absence, or the likelihood of the coronary artery disease in the individual, based at least in part on (i) whether the first angle differs from the second angle by at least 100 degrees, or (ii) whether there is a presence of a third electromagnetic dipole in either the first electromagnetic field map or the second electromagnetic field map.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: GENETESIS, INC.
To: SB TECHNOLOGY, INC.
Reel/Frame 072753/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2025
From: GENETESIS, INC.
To: SB TECHNOLOGY, INC.
Reel/Frame 072583/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2025
From: ERASALA, VINEET; VON STEIN, JON; SEDLAK, TATIANA; PRINCE, JULIA; SENAGORE, ANTHONY; MALTHOTRA, RHEA; SETEGN, EMMANUEL T.; MOORE, BENJAMIN DONALDSON; SHRIVASTAVA, PREEYUSH
To: GENETESIS, INC.
Reel/Frame 071971/0930 →
Continuity (3)
Continuation PCTUS2021034269 · May 26, 2021
Provisional Application 63030536 · May 27, 2020
Related Publication 20230181078A1 · Jun 15, 2023
References Cited (346)
US 4600886A · Jensen · 1986 [cited by applicant]
US 5122744A · Koch · 1992 [cited by applicant]
US 5697369A · Long, Jr. et al. · 1997 [cited by applicant]
US 5715821A · Faupel · 1998 [cited by applicant]
US 5771894A · Richards et al. · 1998 [cited by applicant]
US 5785653A · Kiyuna et al. · 1998 [cited by applicant]
US 6195576B1 · John · 2001 [cited by applicant]
US 6230037B1 · Tsukada et al. · 2001 [cited by applicant]
US 6339328B1 · Keene et al. · 2002 [cited by applicant]
US 6385479B1 · Sibbitt et al. · 2002 [cited by applicant]
US 6390098B1 · LaFontaine et al. · 2002 [cited by applicant]
US 6522908B1 · Miyashita et al. · 2003 [cited by applicant]
US 6597940B2 · Bishop et al. · 2003 [cited by applicant]
US 7270670B1 · Yencho · 2007 [cited by applicant]
US 7395107B2 · Ishiyama et al. · 2008 [cited by applicant]
US 7599728B2 · Feenan · 2009 [cited by applicant]
US 7634360B2 · Davalos et al. · 2009 [cited by applicant]
US 7646274B2 · Rapoport · 2010 [cited by applicant]
US 7801591B1 · Shusterman · 2010 [cited by applicant]
US 7805179B2 · Horng et al. · 2010 [cited by applicant]
US 8060179B1 · Flynn · 2011 [cited by applicant]
US 8172776B2 · Browne · 2012 [cited by third party]
US 8310230B2 · Haensch et al. · 2012 [cited by applicant]
US 8315713B2 · Burnes et al. · 2012 [cited by applicant]
US 8323188B2 · Tran · 2012 [cited by applicant]
US 8553956B2 · Wu et al. · 2013 [cited by applicant]
US 9433363B1 · Erasala et al. · 2016 [cited by applicant]
US 9788741B2 · Erasala et al. · 2017 [cited by applicant]
US 10076256B2 · Erasala et al. · 2018 [cited by applicant]
US 10140421B1 · Bernard et al. · 2018 [cited by applicant]
US 10602940B1 · Muchhala et al. · 2020 [cited by applicant]
US 10925502B2 · Muchhala et al. · 2021 [cited by applicant]
US 10952628B2 · Erasala et al. · 2021 [cited by applicant]
US 11134877B2 · Erasala et al. · 2021 [cited by applicant]
US 11375935B2 · Muchhala et al. · 2022 [cited by applicant]
US 11517235B2 · Muchhala et al. · 2022 [cited by applicant]
US 11585869B2 · Setegn et al. · 2023 [cited by applicant]
US 12097032B2 · Muchhala et al. · 2024 [cited by applicant]
US 12127842B2 · Erasala et al. · 2024 [cited by applicant]
US 12262997B2 · Erasala et al. · 2025 [cited by applicant]
US 20010029329A1 · Avrin et al. · 2001 [cited by applicant]
US 20020045813A1 · Suzuki et al. · 2002 [cited by applicant]
US 20020077537A1 · Avrin et al. · 2002 [cited by applicant]
US 20020103428A1 · deCharms · 2002 [cited by applicant]
US 20030018277A1 · He · 2003 [cited by applicant]
US 20030097056A1 · Suzuki et al. · 2003 [cited by applicant]
US 20030135128A1 · Suffin et al. · 2003 [cited by applicant]
US 20030149354A1 · Bakharev · 2003 [cited by applicant]
US 20040039291A1 · Nakai et al. · 2004 [cited by applicant]
US 20040106863A1 · Seki et al. · 2004 [cited by applicant]
US 20040232912A1 · Tsukamoto et al. · 2004 [cited by applicant]
US 20040243022A1 · Carney et al. · 2004 [cited by applicant]
US 20040254443A1 · Gott et al. · 2004 [cited by applicant]
US 20050020903A1 · Krishnan et al. · 2005 [cited by applicant]
US 20050096531A1 · Oonuma et al. · 2005 [cited by applicant]
US 20050148844A1 · Ogata et al. · 2005 [cited by applicant]
US 20050152703A1 · Ogawa · 2005 [cited by applicant]
US 20050192502A1 · Ishiyama et al. · 2005 [cited by applicant]
US 20050285492A1 · Hu et al. · 2005 [cited by applicant]
US 20060122525A1 · Shusterman · 2006 [cited by applicant]
US 20060149354A1 · Shanley et al. · 2006 [cited by applicant]
US 20060234304A1 · Amann-Zalan et al. · 2006 [cited by applicant]
US 20060277075A1 · Salwan · 2006 [cited by applicant]
US 20070120563A1 · Kawabata et al. · 2007 [cited by applicant]
US 20070167723A1 · Park et al. · 2007 [cited by applicant]
US 20070167846A1 · Sternickel et al. · 2007 [cited by applicant]
US 20070213600A1 · John et al. · 2007 [cited by applicant]
US 20070276270A1 · Tran · 2007 [cited by applicant]
US 20080033312A1 · Nakai et al. · 2008 [cited by applicant]
US 20080091118A1 · Georgopoulos · 2008 [cited by applicant]
US 20080108504A1 · Matsui et al. · 2008 [cited by applicant]
US 20080137927A1 · Altmann et al. · 2008 [cited by applicant]
US 20080306359A1 · Zdeblick et al. · 2008 [cited by applicant]
US 20080306370A1 · Horng · 2008 [cited by examiner]
US 20090149736A1 · Skidmore et al. · 2009 [cited by applicant]
US 20090172773A1 · Moore · 2009 [cited by applicant]
US 20090177107A1 · Guion-Johnson · 2009 [cited by applicant]
US 20090281413A1 · Boyden et al. · 2009 [cited by applicant]
US 20090295385A1 · Brazdeikis et al. · 2009 [cited by applicant]
US 20090295386A1 · Sato et al. · 2009 [cited by applicant]
US 20090299200A1 · Eggenberger et al. · 2009 [cited by applicant]
US 20100004708A1 · Jahns et al. · 2010 [cited by applicant]
US 20100036269A1 · Ferren et al. · 2010 [cited by applicant]
US 20100090697A1 · Savukov et al. · 2010 [cited by applicant]
US 20100249620A1 · Cho · 2010 [cited by applicant]
US 20110041520A1 · Erne et al. · 2011 [cited by applicant]
US 20110047105A1 · Sternickel et al. · 2011 [cited by applicant]
US 20110119212A1 · De Bruin et al. · 2011 [cited by applicant]
US 20110152703A1 · Zuckerman et al. · 2011 [cited by applicant]
US 20110160546A1 · Madsen · 2011 [cited by applicant]
US 20110224962A1 · Goldberger et al. · 2011 [cited by applicant]
US 20110275949A1 · Harlev et al. · 2011 [cited by applicant]
US 20110306896A1 · Altmann · 2011 [cited by applicant]
US 20110313274A1 · Subbarao · 2011 [cited by applicant]
US 20120197145A1 · Wu et al. · 2012 [cited by applicant]
US 20120219195A1 · Wu et al. · 2012 [cited by applicant]
US 20120239560A1 · Pourfallah et al. · 2012 [cited by applicant]
US 20120284332A1 · Pradeep et al. · 2012 [cited by applicant]
US 20120289954A1 · Lam · 2012 [cited by applicant]
US 20120310107A1 · Doidge et al. · 2012 [cited by applicant]
US 20130038325A1 · Okada · 2013 [cited by applicant]
US 20130057385A1 · Murakami et al. · 2013 [cited by applicant]
US 20130072780A1 · Espy et al. · 2013 [cited by applicant]
US 20130079622A1 · Wu et al. · 2013 [cited by applicant]
US 20130096394A1 · Gupta et al. · 2013 [cited by applicant]
US 20130132109A1 · Mruthyunjaya et al. · 2013 [cited by applicant]
US 20130184569A1 · Strommer et al. · 2013 [cited by applicant]
US 20130203061A1 · Kuslich et al. · 2013 [cited by applicant]
US 20130241929A1 · Massarwa et al. · 2013 [cited by applicant]
US 20130317337A1 · Wu et al. · 2013 [cited by applicant]
US 20130324832A1 · Wu et al. · 2013 [cited by applicant]
US 20140107511A1 · Banet et al. · 2014 [cited by applicant]
US 20140171757A1 · Kawato et al. · 2014 [cited by applicant]
US 20140308930A1 · Tran · 2014 [cited by applicant]
US 20140323848A1 · He et al. · 2014 [cited by applicant]
US 20140343396A1 · Sternickel et al. · 2014 [cited by applicant]
US 20140343397A1 · Kim et al. · 2014 [cited by applicant]
US 20140379269A1 · Schmitt · 2014 [cited by applicant]
US 20150011844A1 · Paradis · 2015 [cited by applicant]
US 20150011862A1 · Chaykovskyy · 2015 [cited by applicant]
US 20150080703A1 · Reiman · 2015 [cited by applicant]
US 20150150475A1 · Varcoe · 2015 [cited by applicant]
US 20150212166A1 · Kandori et al. · 2015 [cited by applicant]
US 20150366546A1 · Kamen et al. · 2015 [cited by applicant]
US 20160007879A1 · Gonzalez et al. · 2016 [cited by applicant]
US 20160044841A1 · Chamberlain · 2016 [cited by applicant]
US 20160066860A1 · Sternickel et al. · 2016 [cited by applicant]
US 20160120432A1 · Sridhar et al. · 2016 [cited by applicant]
US 20160131723A1 · Nagasaka · 2016 [cited by applicant]
US 20160135706A1 · Sullivan et al. · 2016 [cited by applicant]
US 20160154072A1 · Nagasaka et al. · 2016 [cited by applicant]
US 20160154073A1 · Nagasaka et al. · 2016 [cited by applicant]
US 20160287166A1 · Tran · 2016 [cited by applicant]
US 20170007148A1 · Kaditz et al. · 2017 [cited by applicant]
US 20170027498A1 · Larson et al. · 2017 [cited by applicant]
US 20170032922A1 · Champeaux et al. · 2017 [cited by applicant]
US 20170053082A1 · Pereira et al. · 2017 [cited by applicant]
US 20170071499A1 · Nebuya et al. · 2017 [cited by applicant]
US 20170135633A1 · Connor · 2017 [cited by applicant]
US 20170173262A1 · Veltz · 2017 [cited by applicant]
US 20170202509A1 · Sanderson et al. · 2017 [cited by applicant]
US 20170258348A1 · Erasala et al. · 2017 [cited by applicant]
US 20170329922A1 · Eberting et al. · 2017 [cited by applicant]
US 20170332918A1 · Keane · 2017 [cited by applicant]
US 20170352158A1 · Raina · 2017 [cited by applicant]
US 20180000371A1 · Gupta et al. · 2018 [cited by applicant]
US 20180064400A1 · Chbat et al. · 2018 [cited by applicant]
US 20180070841A1 · Honore et al. · 2018 [cited by applicant]
US 20180078146A1 · Shadforth et al. · 2018 [cited by applicant]
US 20180078767A1 · Rapoport et al. · 2018 [cited by applicant]
US 20180089531A1 · Geva et al. · 2018 [cited by applicant]
US 20180093092A1 · Howard · 2018 [cited by applicant]
US 20180128886A1 · Nagasaka · 2018 [cited by applicant]
US 20180158552A1 · Liu et al. · 2018 [cited by applicant]
US 20180224508A1 · Kelly et al. · 2018 [cited by applicant]
US 20180235470A1 · Johnson et al. · 2018 [cited by applicant]
US 20180236255A1 · Etkin · 2018 [cited by applicant]
US 20180263561A1 · Jones · 2018 [cited by applicant]
US 20180322351A1 · Shaker · 2018 [cited by applicant]
US 20180333063A1 · Muchhala et al. · 2018 [cited by applicant]
US 20180333104A1 · Sitek · 2018 [cited by applicant]
US 20190018080A1 · Marauska et al. · 2019 [cited by applicant]
US 20190021621A1 · Erasala et al. · 2019 [cited by applicant]
US 20190046059A1 · Erasala · 2019 [cited by examiner]
US 20190108833A1 · van den Oord et al. · 2019 [cited by applicant]
US 20190117164A1 · Gupta et al. · 2019 [cited by applicant]
US 20190167136A1 · Kawabata et al. · 2019 [cited by applicant]
US 20190192021A1 · Kim et al. · 2019 [cited by applicant]
US 20190336231A1 · Kidd et al. · 2019 [cited by applicant]
US 20190365266A1 · Varcoe et al. · 2019 [cited by applicant]
US 20190368191A1 · Shibuya · 2019 [cited by applicant]
US 20200081079A1 · Khitun · 2020 [cited by applicant]
US 20200152330A1 · Anushiravani et al. · 2020 [cited by applicant]
US 20200170528A1 · Erasala et al. · 2020 [cited by applicant]
US 20200187802A1 · Muchhala et al. · 2020 [cited by applicant]
US 20200211713A1 · Shadforth et al. · 2020 [cited by applicant]
US 20200258627A1 · Setegn et al. · 2020 [cited by applicant]
US 20200388287A1 · Anushiravani et al. · 2020 [cited by applicant]
US 20210027893A1 · Nematihosseinabadi et al. · 2021 [cited by applicant]
US 20210325482A1 · Setegn et al. · 2021 [cited by applicant]
US 20220015677A1 · Erasala et al. · 2022 [cited by applicant]
US 20230181077A1 · Muchhala et al. · 2023 [cited by applicant]
US 20230204688A1 · Setegn et al. · 2023 [cited by applicant]
US 20240245335A1 · Erasala et al. · 2024 [cited by applicant]
US 20250000417A1 · Erasala et al. · 2025 [cited by applicant]
CN 1259025A · 2000 [cited by applicant]
CN 1471374A · 2004 [cited by applicant]
CN 101926646A · 2010 [cited by applicant]
CN 102355859A · 2012 [cited by applicant]
CN 104188650A · 2014 [cited by applicant]
CN 204133457U · 2015 [cited by applicant]
CN 104620123A · 2015 [cited by applicant]
CN 113316412A · 2021 [cited by applicant]
EP 1302160A1 · 2003 [cited by applicant]
EP 3077037A1 · 2016 [cited by applicant]
EP 3308703A1 · 2018 [cited by applicant]
EP 3883457A1 · 2021 [cited by applicant]
GB 2179455A · 1987 [cited by applicant]
JP H01274498A · 1989 [cited by applicant]
JP H04206696A · 1992 [cited by applicant]
JP H04319334A · 1992 [cited by applicant]
JP H05317280A · 1993 [cited by applicant]
JP H06283888A · 1994 [cited by applicant]
JP H8126624 · 1996 [cited by applicant]
JP H1183965A · 1999 [cited by applicant]
JP 2000254108A · 2000 [cited by applicant]
JP 2002028144A · 2002 [cited by applicant]
JP 2002355229A · 2002 [cited by applicant]
JP 2004041739A · 2004 [cited by applicant]
JP 2004237083A · 2004 [cited by applicant]
JP 2004337478A · 2004 [cited by applicant]
JP 2005003503A · 2005 [cited by applicant]
JP 2005080951A · 2005 [cited by applicant]
JP 2005217341A · 2005 [cited by applicant]
JP 2006094984A · 2006 [cited by applicant]
JP 2007117669A · 2007 [cited by applicant]
JP 2008307141A · 2008 [cited by applicant]
JP 2012095939A · 2012 [cited by applicant]
JP 2012110489A · 2012 [cited by applicant]
JP 2014525787A · 2014 [cited by applicant]
JP 2015091359A · 2015 [cited by applicant]
JP 2016012501A · 2016 [cited by applicant]
JP 2016101264A · 2016 [cited by applicant]
JP 2016530019A · 2016 [cited by applicant]
KR 20180046432A · 2018 [cited by applicant]
WO WO1998049938A1 · 1998 [cited by applicant]
WO WO2002017769A2 · 2002 [cited by applicant]
WO WO2005002313A2 · 2005 [cited by applicant]
WO WO2008005513A2 · 2008 [cited by applicant]
WO WO2011116229A2 · 2011 [cited by applicant]
WO WO2013011515A1 · 2013 [cited by applicant]
WO WO2014011940A2 · 2014 [cited by applicant]
WO WO2014152110A1 · 2014 [cited by applicant]
WO WO2015033244A1 · 2015 [cited by applicant]
WO WO2015085011A1 · 2015 [cited by applicant]
WO WO2015129756A1 · 2015 [cited by applicant]
WO WO2016205731A1 · 2016 [cited by applicant]
WO WO2018069287A1 · 2018 [cited by applicant]
WO WO2018217655A1 · 2018 [cited by applicant]
WO WO2019032857A1 · 2019 [cited by applicant]
WO WO2019077865A1 · 2019 [cited by applicant]
WO WO2020106284A1 · 2020 [cited by applicant]
WO WO2020163593A1 · 2020 [cited by applicant]
WO WO20210242868A1 · 2021 [cited by applicant]
WO WO2022178314A1 · 2022 [cited by applicant]
WO WO2023168392A2 · 2023 [cited by applicant]
Park, Magnetocardiography Predicts Coronary Artery Disease in Patients with Acute Chest Pain, 2005 (Year: 2005). [cited by examiner]
Amsterdam, E.A., et al., Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association, Circulation, 122(17): 1756-1776 (2010). [cited by applicant]
Arbab-Zadeh, A., Stress testing and non-invasive coronary angiography in patients with suspected coronary artery disease: time for a new paradigm, Heart Int, 7(1): e2 (2012). [cited by applicant]
Bousaa, M., et al., ECG signals classification using MFCC coefficients and ANN classifier, 2nd International Conference on Electrical and Information Technologies ICEIT, pp. 1-5 (2016). [cited by applicant]
CN201880048311.1 Chinese Office Action dated Mar. 8, 2022. [cited by applicant]
EP Application No. 16812571.4 94(3) Communication dated Aug. 30, 2021. [cited by applicant]
EP Application No. 18940759.6 Extended European Search Report dated Jun. 3, 2022. [cited by applicant]
EP18805647.7 Extended European Search Report dated Dec. 17, 2020. [cited by applicant]
EP18844754.4 Extended European Search Report dated Mar. 12, 2021. [cited by applicant]
Fenici, R., et al., Clinical validation of machine learning for automatic analysis of multichannel magnetocardiography, Proceedings of the Third International Conference on Functional Imaging and Modeling of the Heart (… [cited by applicant]
Haberkorn, W., et al., Pseudo current density maps of electrophysiological heart, nerve or brain function and their physical basis, Biomagn Res Technol, 4:5 (2006). [cited by applicant]
He, K., et al., A high-performance compact magnetic shield for optically pumped magnetometer-based magnetoencephalography, Rev Sci Instrum, 90(6): 064102, pp. 1-8 (2019). [cited by applicant]
Heron, M., et al., Deaths: Leading Causes for 2014, Natl Vital Stat Rep, 65(5): 1-96 (2016). [cited by applicant]
JP2019-564526 Japanese Office Action dated Jan. 25, 2023. [cited by applicant]
JP2019-564526 Japanese Office Action dated Mar. 22, 2022. [cited by applicant]
Jurkko, R., et al., Non-invasive detection of conduction pathways to left atrium using magnetocardiography: validation by intra-cardiac electroanatomic mapping, Eurospace, 11(2): 169-177 (2009). [cited by applicant]
Killman, R., et al., Localisation of myocardial ischaemia from the magnetocardiogram using current density reconstruction method: computer simulation study, Med Biol Eng Comput, 33(5): 643-651 (1995). [cited by applicant]
Liao, Y., et al., Denoising of Magnetocardiography Based on Improved Variational Mode Decomposition and Interval Thresholding Method, Symmetry, 10(7): 269 (2018). [cited by applicant]
Lyons, J., Mel Frequency Cepstral Coefficient (MFCC) tutorial, retrieved on Jun. 6, 2017 from <http://practicalcryptography.com/miscellaneous/machine-learning/guide-mel-frequency-cepstral-coefficients-mfccs/>. [cited by applicant]
Moseley, M.G., et al., Emergency department observation units and the older patient, Clin Geriatr Med, 29(1): 71-89 (2013). [cited by applicant]
Park, J-W., et al., Magnetocardiography predicts coronary artery disease in patients with acute chest pain, Ann Noninvasive Electrocardiol, 10(3): 312-323 (2005). [cited by applicant]
PCT/US2016/038209 International Preliminary Report on Patentability mailed Dec. 28, 2017. [cited by applicant]
PCT/US2016/038209 International Search Report and Written Opinion mailed Sep. 14, 2016. [cited by applicant]
PCT/US2018/033719 International Preliminary Report on Patentability mailed Nov. 26, 2019. [cited by applicant]
PCT/US2018/033719 International Search Report and Written Opinion mailed Aug. 27, 2018. [cited by applicant]
PCT/US2018/046055 International Preliminary Report on Patentability mailed Feb. 11, 2020. [cited by applicant]
PCT/US2018/046055 International Search Report and Written Opinion mailed Oct. 17, 2018. [cited by applicant]
PCT/US2018/062113 International Search Report and Written Opinion mailed Jan. 31, 2019. [cited by applicant]
PCT/US2020/017010 International Preliminary Report on Patentability dated Aug. 10, 2021. [cited by applicant]
PCT/US2020/017010 International Search Report and Written Opinion mailed May 4, 2020. [cited by applicant]
PCT/US2021/034269 International Preliminary Report on Patentability mailed Nov. 17, 2022. [cited by applicant]
PCT/US2021/034269 International Search Report and Written Opinion mailed Sep. 8, 2021. [cited by applicant]
PCT/US2022/017085 International Preliminary Report on Patentability dated Aug. 22, 2023. [cited by applicant]
PCT/US2022/017085 International Search Report and Written Opinion mailed Mar. 14, 2022. [cited by applicant]
PCT/US2023/063666 International Search Report and Written Opinion mailed Sep. 5, 2023. [cited by applicant]
Ramesh, R., et al., Magnetocardiography for identification of coronary ischemia in patients with chest pain and normal resting 12-lead electrocardiogram, Ann Noninvasive Electrocadiol, 25(3): e12715 (2020). [cited by applicant]
Reinhardt, S.W., et al., Noninvasive Cardiac Testing vs Clinical Evaluation Alone in Acute Chest Pain: A Secondary Analysis of the ROMICAT-II Randomized Clinical Trial, JAMA Intern Med, 178(2): 212-219 (2018). [cited by applicant]
Sasada, I., et al., Effective shielding for low-level magnetic fields, J Appl Phys, 64(10): 5696-5698 (1988). [cited by applicant]
Tantimongcolwat, T., et al., Identification of ischemic heart disease via machine learning analysis on magnetocardiograms, Comput Biol Med, 38(7): 817-825 (2008). [cited by applicant]
U.S. Appl. No. 16/197,264 Office Action mailed Feb. 5, 2019. [cited by applicant]
U.S. Appl. No. 16/197,264 Office Action mailed Jul. 31, 2019. [cited by applicant]
U.S. Appl. No. 16/775,630 Office Action mailed Apr. 23, 2020. [cited by applicant]
U.S. Appl. No. 17/129,585 Office Action mailed Apr. 16, 2021. [cited by applicant]
U.S. Appl. No. 17/129,585 Office Action mailed Aug. 24, 2021. [cited by applicant]
U.S. Appl. No. 17/830,879 Office Action mailed Mar. 31, 2023. [cited by applicant]
U.S. Appl. No. 14/941,455 Notice of Allowance mailed Jul. 7, 2016. [cited by applicant]
U.S. Appl. No. 14/941,455 Office Action mailed Apr. 4, 2016. [cited by applicant]
U.S. Appl. No. 14/941,455 Office Action mailed Feb. 17, 2016. [cited by applicant]
U.S. Appl. No. 15/220,982 Notice of Allowance mailed May 9, 2017. [cited by applicant]
U.S. Appl. No. 15/220,982 Office Action mailed Dec. 27, 2016. [cited by applicant]
U.S. Appl. No. 15/601,417 Office Action dated Sep. 27, 2017. [cited by applicant]
U.S. Appl. No. 15/607,053 Notice of Allowance mailed May 15, 2018. [cited by applicant]
U.S. Appl. No. 15/607,053 Office Action mailed Dec. 22, 2017. [cited by applicant]
U.S. Appl. No. 15/673,067 Office Action dated Feb. 5, 2021. [cited by applicant]
U.S. Appl. No. 15/673,067 Office Action dated May 11, 2020. [cited by applicant]
U.S. Appl. No. 15/673,067 Office Action dated Oct. 13, 2020. [cited by applicant]
U.S. Appl. No. 15/985,512 Notice of Allowance dated Jul. 27, 2022. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Feb. 11, 2022. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Feb. 12, 2021. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Sep. 21, 2021. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Sep. 25, 2020. [cited by applicant]
U.S. Appl. No. 16/104,528 Office Action mailed Feb. 26, 2020. [cited by applicant]
U.S. Appl. No. 16/104,528 Office Action mailed Nov. 7, 2019. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated Aug. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated Jan. 9, 2020. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated Jul. 1, 2019. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated May 1, 2020. [cited by applicant]
U.S. Appl. No. 16/636,860 Office Action dated Feb. 28, 2024. [cited by applicant]
U.S. Appl. No. 16/636,860 Office Action dated Jul. 18, 2022. [cited by applicant]
U.S. Appl. No. 16/636,860 Office Action dated Nov. 9, 2023. [cited by applicant]
U.S. Appl. No. 17/181,095 Office Action dated Jun. 3, 2021. [cited by applicant]
U.S. Appl. No. 17/181,095 Office Action dated Mar. 29, 2022. [cited by applicant]
U.S. Appl. No. 17/181,095 Office Action dated Sep. 29, 2021. [cited by applicant]
U.S. Appl. No. 17/403,029 Office Action dated Dec. 7, 2022. [cited by applicant]
U.S. Appl. No. 17/403,029 Office Action dated Oct. 6, 2023. [cited by applicant]
U.S. Appl. No. 17/403,029 Office Action mailed Jan. 29, 2024. [cited by applicant]
U.S. Appl. No. 17/972,889 Office Action mailed Feb. 1, 2024. [cited by applicant]
Watanabe, S., et al., Magnetocardiography in Early Detection of Electromagnetic Abnormality in Ischemic Heart Disease, J Arrhythmia, 24(1): 4-17 (2008). [cited by applicant]
Algra, A., et al., Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death, Circulation, 88(1): 180-185 (1993). [cited by applicant]
Ashokprabhu, N., et al., Evaluation of coronary microvascular dysfunction using magnetocardiography: A new application to an old technology, Am Heart J Plus, 44: 100424, pp. 1-7 (2024). [cited by applicant]
Chen, J., et al., Age and sex dependent variations in the normal magnetocardiogram compared with changes associated with ischemia, Ann Biomed Eng, 32(8): 1088-1099 (2004). [cited by applicant]
Desai, A.D., et al., Prognostic Significance of Quantitative QRS Duration, Am J Med, 119(7): 600-606 (2006). [cited by applicant]
Fenici, R., et al., Clinical application of magnetocardiography, Expert Rev Mol Diagn, 5(3): 291-313 (2005). [cited by applicant]
Hänninen, H., et al., Features of ST segment and T-wave in exercise-induced myocardial ischemia evaluated with multichannel magnetocardiography, Ann Med, 34(2): 120-129 (2002). [cited by applicant]
Kataoka, H., et al., Changes in the amplitude of electrocardiogram QRS complexes during follow-up of heart failure patients, J Electrocardiol, 44(3):394.e1-9 (2011). [cited by applicant]
Kelshiker, M.A., et al., Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis, Eur Heart J, 43(16): 1582-1593 (2022). [cited by applicant]
Kurl, S., et al., Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men, Circulation, 125(21): 2588-2594 (2012). [cited by applicant]
Mace, S.E., et al., Accelerated magnetocardiography in the evaluation of patients with suspected cardiac ischemia: The MAGNETO trial, Am Heart J Plus, 40: 100372, pp. 1-7 (2024). [cited by applicant]
Malik, M., et al., Heart rate variability: Standards of measurement, physiological interpretation, and clinical use, Eur Heart J, 17(3): 354-381 (1996). [cited by applicant]
Oehler, A., et al., QRS-T angle: a review, Ann Noninvasive Electrocardiol, 19(6): 534-542 (2014). [cited by applicant]
Peguero, J.G., et al., Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy, J Am Coll Cardiol, 69(13): 1694-1703 (2017). [cited by applicant]
Sara, J.D., et al., Electrocardiographic predictors of coronary microvascular dysfunction in patients with non-obstructive coronary artery disease: Utility of a novel T wave analysis program, Int J Cardiol, 203: 601-606… [cited by applicant]
Specifications for the CMI 2409 Magnetocardiograph, pp. 1-6 (2006). [cited by applicant]
Sugrue, A., et al., Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy, Open Heart, 4(1): e000561 (2017). [cited by applicant]
Taha, Y.K., et al., Electrocardiographic (ECG) predictors of major adverse cardiac events in women with ischemia and no obstructive coronary artery disease (INOCA), Eur Heart J, 41(Suppl 2): 3188 (2020). [cited by applicant]
Tao, R., et al., Magnetocardiography-Based Ischemic Heart Disease Detection and Localization Using Machine Learning Methods, IEEE Trans Biomed Eng, 66(6): 1658-1667 (2019). [cited by applicant]
Tsukada, K., et al., An iso-integral mapping technique using magnetocardiogram, and its possible use for diagnosis of ischemic heart disease, Int J Card Imaging, 16(1): 55-66 (2000). [cited by applicant]
Van Leeuwen, P., et al., Changes in dipolar structure of cardiac magnetic field maps after ST elevation myocardial infarction, Ann Noninvasive Electrocardiol, 16(4): 379-387 (2011). [cited by applicant]
Voulgari, C., et al., Assessment of the Spatial QRS-T Angle by Vectorcardiography: Current Data and Perspectives, Curr Cardiol Rev, 5(4): 251-262 (2009). [cited by applicant]
Zhang, Y., et al., Electrocardiographic QT interval and mortality: a meta-analysis, Epidemiology, 22(5): 660-670 (2011). [cited by applicant]